Impact of pneumococcal conjugate vaccines on healthcare utilization and direct costs for otitis media in children ≤2 years of age in two Swedish regions

In Sweden, the 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2009 and replaced by the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) or the 13-valent PCV (PCV13) from late 2009. We assessed the impact of PCVs on rates of antibiotic prescribi...

Descripción completa

Detalles Bibliográficos
Autores principales: Edmondson-Jones, Mark, Dibbern, Therese, Hultberg, Marcus, Anell, Bengt, Medin, Emma, Feng, Yang, Talarico, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Pneumococcal – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920213/
https://www.ncbi.nlm.nih.gov/pubmed/34319865
http://dx.doi.org/10.1080/21645515.2021.1942712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920213/
https://www.ncbi.nlm.nih.gov/pubmed/34319865
http://dx.doi.org/10.1080/21645515.2021.1942712

Ejemplares similares